Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings

British Journal of General Practice

Volumn 60, Issue 570, 2010, Pages 21-27

  Bojke, Chris ^a   Philips, Z ^a   Sculpher, M ^a   Campion, P ^b   Chrystyn, H ^c   Coulton, S ^d   Cross, B ^a   Morton, V ^a   Richmond, S ^a   Farrin, A ^e   Hill, G ^f   Hilton, A ^b   Miles, J ^g   Russell, I ^h   Chi Kei Wong, I ⁱ  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^d UNIVERSITY OF KENT   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f East Riding and Hull Local Pharmaceutical Committee   (United Kingdom)

^g RAND CORPORATION   (United States)

^h SWANSEA UNIVERSITY   (United Kingdom)

ⁱ UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cost effectiveness; Health services for the aged; Medication therapy management; Pharmaceutical care

Indexed keywords

AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; GERIATRIC CARE; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HUMAN; MEDICAL RECORD REVIEW; PATIENT CARE; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

EID: 76049091757     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp09X482312     Document Type: Article

References (19)

1. RESPECT trial team. Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract 2009; DOI: 10.3399/bjgp09X473295.
2. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2004.
3. Rabin R, Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-343.
4. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008.
5. Curtis L, Nerton A. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent; 2005.
6. Surelines Pharmaceutical Services. Drug tariff. Blisworth: Surelines Ltd, 2005. http://www.drugtariff.com (accessed 19 Nov 2009).
7. Monthly price list - December 2005. Chemist and Druggist 2006; 46: 12.
8. Chartered Institute of Public Finance and Accountancy. Returns 2005. London: CIPFA; 2006.
9. Frolich M. Programme evaluation with multiple treatments. Journal of Economic Surveys 2004; 18:181-224.
10. Skrondal A, Rabe-Hesketh S. Generalized latent variable modeling: multilevel, longitudinal and structural equation models. Boca Raton: Chapman and Hall, 2004.
11. Drummond MF, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press, 2005.
12. Creaky GE, Sturgess IK, McElnay JC, Hughes CM. Pharmaceutical care programmes for the elderly: economic issues. Pharmacoeconomics 2003; 21:455-465.
13. Bond C, Matheson C, Williams S, et al. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000; 50: 271-275.
14. Manley HJ, Carroll CA. The clinical and economic impact of pharmaceutical care in end stage renal disease patients. Semin Dial 2002; 15:45-49.
15. Etemad L, Hay J. Cost-effectiveness analysis of pharmaceutical care in a Medicare drug benefit program. Value Health 2003; 6(4): 425-435.
16. Kennie NR, Schuster BG, Einarson TR. Critical analysis of the pharmaceutical care research literature. Ann Pharmacother 1998; 32: 17-26.
17. Bernsten C, Bjorkman I, Caramona M, et al. Improving the wellbeing of elderly patients via community pharmacy-based provision of pharmaceutical care: a multi-centre study in seven European countries. Drugs Aging 2001; 18:63-77.
18. Sturgess IK, McElnay JC, Hughes CM, Creaky G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003; 25:218-226.
19. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999; 18:341-364.